United Kingdom · How much has Yellowstone Biosciences raised?
Yellowstone Biosciences has raised $21M across 2 rounds since 2024.
2025
$185KRound$21MSeries A
United Kingdom · Series A startup
Who invested in Yellowstone Biosciences
2 rounds we have observed, with the 0 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow Yellowstone Biosciences and see its new rounds in your feed. Start following
Funding summaryUpdated 15 Nov 2026
$21Mraised across 2 rounds since 2024, from 2 sources
$185KRound$21MSeries A
- Latest round
- Series A, $21MJun 2024
- Step-upi
- 113.1×
- Investors
- 0
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Round, $185K Mar 2024
- Biggest round
- $21M Series A · Jun 2024
- Between rounds
- 2 months from the last two
The rounds
- Jun 2024Series A$21M
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
- Mar 2024Round$185K
No investor was named in the report.
Shares issued, filed with Companies House (SH01); no report of this raise yet
Funding filed with regulators
Yellowstone Biosciences filed 2 raises, $21M in all. Filings say how much was sold and to how many investors; they never name the investors.
- Jun 2024$21MUK share allotment
- Mar 2024$185KUK share allotment
Founders and team
From Yellowstone Biosciences's own website: 2 founders, 4 on the team.
Julian HirstCo-Founder and Chief Financial Officer
Professor Paresh VyasCo-Founder and Chief Scientific Officer
- Jim MacDonaldChief Executive Officer
- Dr. Ita O’KellyChief Operating Officer
- Gonzalo GarciaInterim Chief Business Officer
- Chris HollowoodNon-Executive Director
Quick answers about Yellowstone Biosciences
When did Yellowstone Biosciences last raise?
Yellowstone Biosciences's most recent round was a Series A of $21M in Jun 2024.
What was Yellowstone Biosciences's biggest round?
Its most recent round, $21M in Jun 2024, is also its largest on record.
What stage is Yellowstone Biosciences at?
Yellowstone Biosciences's latest named round is a Series A, in Jun 2024.
Where is Yellowstone Biosciences based?
Yellowstone Biosciences is based in the United Kingdom.
Companies like Yellowstone Biosciences
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.